Aurobindo Pharma Ltd. (AUROPHARMA)
Market Closed
10 Aug, 22:00
MSE XNSE Primary MSE ₹
1,646. 00
-15
-0.9031%
₹
- Market Cap
- P/E Ratio
6% Div Yield
49,631 Volume
- Eps
₹ 1,661
Previous Close Want to track AUROPHARMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 16.88 | - |
| | | 15.89 | - |
| | | 15.24 | - |
| | | - | - |
| | | 17.79 | 15.56 |
| | | 15.54 | 14.56 |
| | | 16.29 | 14.07 |
| | | 16.2 | 15.69 |
| | | 14.53 | 17.59 |
| | | - | - |
| | | - | 12.92 |
| | | - | 10.35 |
| | | - | 10 |
| | | - | 9.62 |
| | | - | 9.16 |
| | | - | 7.73 |
| | | - | 7.4 |
| | | - | 6.92 |
| | | - | 6.58 |
| | | - | 6.38 |
| | | - | 7.12 |
| | | - | 8.61 |
| | | - | 7.16 |
| | | - | 4.03 |
| | | - | 0.32 |
| | | - | 1.86 |
| | | - | 1.58 |
AUROPHARMA Earnings Reports FAQ
What is the earnings per share (EPS) for AUROPHARMA?
EPS data for AUROPHARMA is currently not available, as Aurobindo Pharma Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 21.02%, reflecting the AUROPHARMA's performance and MSE market conditions.
When is the next earnings release date?
Aurobindo Pharma Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Aurobindo Pharma Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for AUROPHARMA at this time, as Aurobindo Pharma Ltd has no recent EPS data to calculate it.
